MARKET

SLRX

SLRX

Salarius Pharmaceuticals Inc
NASDAQ
3.150
-0.350
-10.00%
Opening 13:13 07/26 EDT
OPEN
3.200
PREV CLOSE
3.500
HIGH
3.440
LOW
2.740
VOLUME
926.60K
TURNOVER
0
52 WEEK HIGH
12.48
52 WEEK LOW
1.350
MARKET CAP
1.88M
P/E (TTM)
-0.1451
1D
5D
1M
3M
1Y
5Y
1D
Why Edwards Lifesciences Shares Are Trading Lower? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Edwards Lifesciences Corporation shares dipped 26.9% to $63.60 on Thursday. The company reported worse-than-expected second-quarter sales results and issued third-quarter guidance below estimates. Predictive Oncology Inc. Shares jumped 85% after the company announced successful ovarian cancer study.
Benzinga · 1d ago
BUZZ-U.S. STOCKS ON THE MOVE-AbbVie, NYCB, Warner Bros Discovery
Nasdaq and the S&P reversed early losses. Dow and small-cap stocks outperformed. Stronger-than-expected GDP data provided some relief to Wall Street. AbbVie, NYCB, Warner Bros Discovery and LATAM Airlines Group among top gainers.
Reuters · 1d ago
BUZZ-U.S. STOCKS ON THE MOVE-Universal Health Services, Robert Half, Lazard
Wall Street's main indexes were mixed on Thursday. The Dow Jones Industrial Average was up 0.85% at 40,192.32. The top three S&P 500 percentage gainers were LATAM Airlines Group, Bally's and Molina Healthcare. The Nasdaq Composite was down 0.11%.
Reuters · 1d ago
Dow Jumps 200 Points; Honeywell Trims Profit Outlook
U.S. Stocks traded mixed on Thursday, with the Dow Jones gaining over 200 points. The NASDAQ fell 1.25% and the S&P 500 fell 0.38% on Thursday. Honeywell International reported second-quarter results and lowered FY24 EPS guidance. Asian markets closed lower and European shares were mostly lower.
Benzinga · 1d ago
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
Dermata Therapeutics stock is rocketing more than 123% alongside heavy pre-market trading. Biggest Pre-Market Stock Movers: 10 Top Gainers and 10 Top Losers for Wednesday morning. A new partnership, a public offering, clinical trial news and more are moving stocks this morning.
Investorplace · 2d ago
Why Is Salarius Pharmaceuticals (SLRX) Stock Up 90% Today?
Genomic therapeutic specialist Salarius Pharmaceuticals (NASDAQ:SLRX) shares gained 160% on Tuesday. The biotech firm is in the early stages of developing drugs for cancer treatment. The company recently announced an at-the-market offering of up to $810,000. Investors may be speculating that SLRX stock may receive a financial lifeline.
Investorplace · 3d ago
BUZZ-U.S. STOCKS ON THE MOVE-Lockheed Martin, NBT Bancorp, Centene
Dow Jones Industrial Average was up 0.13% at 40,468.36. United Parcel Service hit a four-year low on weak results. Alphabet and Tesla are expected to report their earnings on Tuesday. The top three S&P 500 percentage gainers were Pentair plc, GE Aerospace and Azitra.
Reuters · 3d ago
Why Comcast Shares Are Trading Lower By 6%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Comcast Corporation shares fell 6.1% to $37.12 on Tuesday. The company reported worse-than-expected second-quarter sales results. Azitra, Inc. Shares jumped 529% after company received patent for treatment of atopic dermatitis. Other stocks moving in the mid-day session include GE Aerospace and Owens & Minor.
Benzinga · 3d ago
More
About SLRX
Salarius Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is developing treatments for parties with cancers in need of new treatment options. Its product portfolio includes seclidemstat, an oral novel small molecule inhibitor of the LSD1 enzyme and the Company's lead candidate, which is being studied as a potential treatment for pediatric cancers, sarcomas, and other cancers with limited treatment options, and SP-3164, an oral small molecule protein degrader being developed for the treatment of Non-Hodgkins Lymphoma. SP-3164 is a small molecule protein degrader, and seclidemstat (SP-2577) is a small molecule inhibitor. SP-3164 is a next-generation cereblon-binding molecular glue (MG). SP-2577 is a small-molecule LSD1 inhibitor with a novel scaffold. The molecule was discovered using structure-based computational screening coupled with chemical screening and further optimization with structure-activity relationship studies.

Webull offers Salarius Pharmaceuticals Inc stock information, including NASDAQ: SLRX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SLRX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading SLRX stock methods without spending real money on the virtual paper trading platform.